You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Glenmark Pharmaceuticals Ltd jumps around 2%

Capital Market 

Glenmark Pharmaceuticals Ltd is quoting at Rs 530, up 1.97% on the day as on 12:54 IST on the NSE. The stock is up 13.03% in last one year as compared to a 34.53% gain in NIFTY and a 14.62% gain in the Nifty Pharma index.

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 530, up 1.97% on the day as on 12:54 IST on the NSE. The benchmark NIFTY is up around 0.32% on the day, quoting at 17470.9. The Sensex is at 58548.02, up 0.35%. Glenmark Pharmaceuticals Ltd has added around 4.35% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has added around 3.18% in last one month and is currently quoting at 13408.1, up 0.88% on the day. The volume in the stock stood at 14.23 lakh shares today, compared to the daily average of 15.99 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 531.6, up 2.21% on the day. Glenmark Pharmaceuticals Ltd is up 13.03% in last one year as compared to a 34.53% gain in NIFTY and a 14.62% gain in the Nifty Pharma index.

The PE of the stock is 9.05 based on TTM earnings ending September 21.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, November 25 2021. 13:05 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU